Acute kidney injury (AKI) after any type of intervention negatively impacts
mortality, length of hospitalization, and perhaps long-term survival. In the
case of endovascular aneurysm repair (EVAR), the incidence of AKI ranges from
1% to 23% for elective and emergency procedures and is lower
compared to open repair. The pathophysiology of AKI in EVAR is complex:
contrast-induced nephropathy, renal microembolization, and acute tubular
necrosis are all implicated. Prevention strategies include hydration, ischemic
preconditioning, regional anesthesia, and pharmacological agents. There is no
level I evidence regarding the prevention of AKI in EVAR, so this review sought
to examine the mechanisms and prevention strategies for this potentially fatal
complication.
SvensjoSBjorckMGurtelschmidM. Low prevalence of abdominal aortic
aneurysm among 65-year-old Swedish men indicates a change in the
epidemiology of the disease. Circulation.
2011;124:1118–1123.
3.
NormanPEJamrozikKLawrence-BrownMM. Population based randomised
controlled trial on impact of screening on mortality from abdominal aortic
aneurysm. BMJ.
2004;329(7477):1259.
4.
LovegroveREJavidMMageeTR. A meta-analysis of 21,178 patients
undergoing open or endovascular repair of abdominal aortic
aneurysm. Br J Surg.
2008;95:677–684.
5.
BiancariFCataniaAD'AndreaV.
Elective endovascular vs. open repair for abdominal aortic
aneurysm in patients aged 80 years and older: systematic review and
meta-analysis. Eur J Vasc Endovasc Surg.
2011;42:571–576.
6.
MorgeraSKraftAKSiebertG. Long-term outcomes in acute renal
failure patients treated with continuous renal replacement
therapies. Am J Kidney Dis.
2002;40:275–279.
7.
KazmersAJacobsLPerkinsA.
The impact of complications after vascular surgery in
Veterans Affairs Medical Centers. J Surg
Res.
1997;67:62–66.
8.
JohnstonKW.
Multicenter prospective study of nonruptured abdominal aortic
aneurysm. Part II. Variables predicting morbidity and
mortality. J Vasc Surg.
1989;9:437–447.
9.
ChertowGMBurdickEHonourM. Acute kidney injury, mortality,
length of stay, and costs in hospitalized patients.
J Am Soc Nephrol.
2005;16:3365–3370.
LoefBGEpemaAHSmildeTD. Immediate postoperative renal
function deterioration in cardiac surgical patients predicts in-hospital
mortality and long-term survival. J Am Soc
Nephrol.
2005;16:195–200.
12.
McCulloughPAAdamABeckerCR. Epidemiology and prognostic
implications of contrast-induced nephropathy. Am J
Cardiol.
2006;98(6A):5K–13K.
13.
McCulloughPAWolynRRocherLL. Acute renal failure after coronary
intervention: incidence, risk factors, and relationship to
mortality. Am J Med.
1997;103:368–375.
14.
JamesMTGhaliWAKnudtsonML. Associations between acute kidney
injury and cardiovascular and renal outcomes after coronary
angiography. Circulation.
2011;123:409–416.
15.
BellomoRRoncoCKellumJA. Acute renal failure - definition,
outcome measures, animal models, fluid therapy and information technology
needs: the Second International Consensus Conference of the Acute Dialysis
Quality Initiative (ADQI) Group. Crit Care.
2004;8:R204–212.
16.
MehtaRLKellumJAShahSV. Acute Kidney Injury Network: report
of an initiative to improve outcomes in acute kidney injury.
Crit Care.
2007;11:R31.
17.
WaldRWaikarSSLiangosO. Acute renal failure after
endovascular vs open repair of abdominal aortic aneurysm.
J Vasc Surg.
2006;43:460–466.
18.
GilesKAHamdanADPomposelliFB. Population-based outcomes following
endovascular and open repair of ruptured abdominal aortic
aneurysms. J Endovasc Ther.
2009;16:554–564.
19.
GilesKAPomposelliFBHamdanAD. Comparison of open and endovascular
repair of ruptured abdominal aortic aneurysms from the ACS-NSQIP
2005–07. J Endovasc Ther.
2009;16:365–372.
20.
AbrahamCZChuterTAReillyLM. Abdominal aortic aneurysm repair with
the Zenith stent graft: short to midterm results. J
Vasc Surg.
2002;36:217–224.
21.
PrinssenMVerhoevenELButhJ. A randomized trial comparing
conventional and endovascular repair of abdominal aortic
aneurysms. N Engl J Med.
2004;351:1607–1618.
22.
MillsJLDuongSTLeonLR. Comparison of the effects of open and
endovascular aortic aneurysm repair on long-term renal function using
chronic kidney disease staging based on glomerular filtration
rate. J Vasc Surg.
2008;47:1141–1149.
23.
AdriaensenMEBoschJLHalpernEF. Elective endovascular vs. open
surgical repair of abdominal aortic aneurysms: a systemic review of
short-term results. Radiology.
2002;224:739–747.
24.
BlankensteijnJDde JongSEPrinssenM.; Dutch Randomized Endovascular
Aneurysm Management (DREAM) Trial Group. Two-year outcomes after
conventional or endovascular repair of abdominal aortic
aneurysms. N Engl J Med.
2005;352:2398–2405.
25.
GawendaMBrunkwallJ.
Renal response to open and endovascular repair of abdominal
aortic aneurysm: a prospective study. Ann Vasc
Surg.
2008;22:1–4.
26.
HuaHTCambriaRPChuangSK. Early outcomes of endovascular vs.
open abdominal aortic aneurysm repair in the National Surgical Quality
Improvement Program-Private Sector. J Vasc
Surg.
2005;41:382–389.
27.
ParmerSSCarpenterJP.
Endovascular aneurysm repair with suprarenal vs infrarenal
fixation: a study of renal effects. J Vasc
Surg.
2006;43:19–25.
28.
CayneNSRheeSJVeithFJ. Does transrenal fixation of aortic
endografts impair renal function?J Vasc Surg.
2003;38:639–644.
29.
GabrielR.
Time to scrap creatinine clearance?Br Med J (Clin Res Ed).
1986;293:1119–1120.
30.
LapsleyMAkersKNordenAG.
Sensitive assays for urinary retinol-binding protein and
beta-2-glycoprotein-1 based on commercially available
standards. Ann Clin Biochem.
1998;35 (Pt
1):115–119.
31.
SmithFCGoslingPSangheraK. Microproteinuria predicts the
severity of systemic effects of reperfusion injury following infrarenal
aortic aneurysm surgery. Ann Vasc Surg.
1994;8:1–5.
32.
MooreNNLapsleyMNordenAG. Does N-acetylcysteine prevent
contrast-induced nephropathy during endovascular AAA repair? A randomized
controlled pilot study. J Endovasc Ther.
2006;13:660–666.
33.
BoyleJRGoodallSThompsonJP. Endovascular AAA repair attenuates
the inflammatory and renal responses associated with conventional
surgery. J Endovasc Ther.
2000;7:359–371.
34.
PriceRG.
The role of NAG (N-acetyl-beta-D-glucosaminidase) in the
diagnosis of kidney disease including the monitoring of
nephrotoxicity. Clin Nephrol.
1992;38Suppl 1:S14–19.
35.
SaratzisASarafidisPMelasN. Suprarenal graft fixation in
endovascular abdominal aortic aneurysm repair is associated with a decrease
in renal function. J Vasc Surg.
2012;56:594–600.
36.
MelasNSaratzisASaratzisN. Aortic and iliac fixation of seven
endografts for abdominal-aortic aneurysm repair in an experimental model
using human cadaveric aortas. Eur J Vasc Endovasc
Surg.
2010;40:429–435.
37.
SubediSKLeeAMLandisGS.
Suprarenal fixation barbs can induce renal artery occlusion
in endovascular aortic aneurysm repair. Ann Vasc
Surg.
2010;24:113,e7–e10.
38.
LeeWHJungGS.
Renal artery dissection during repositioning of a
mal-deployed aortic endograft with suprarenal fixation.
Eur J Vasc Endovasc Surg.
2010;40:736–738.
39.
KrämerSCSeifarthHPamlerR. Renal infarction following
endovascular aortic aneurysm repair: incidence and clinical
consequences. J Endovasc Ther.
2002;9:98–102.
40.
BoulesTNStanzialeSFChomicA. Predictors of diffuse renal
microembolization following endovascular repair of abdominal aortic
aneurysms. Vascular.
2007;15:18–23.
41.
AlsacJMZarinsCKHeikkinenMA. The impact of aortic endografts on
renal function. J Vasc Surg.
2005;41:926–930.
42.
DaveyPRoseJDParkinsonT. The midterm effect of bare metal
suprarenal fixation on renal function following endovascular abdominal
aortic aneurysm repair. Eur J Vasc Endovasc
Surg.
2006;32:516–522.
43.
CotroneoARIezziRGiancristofaroD. Endovascular abdominal aortic
aneurysm repair and renal complications: a comparison between suprarenal and
infrarenal fixation of stent grafts. Radiol
Med.
2007;112:252–263.
44.
LauLLHakaimAGOldenburgWA. Effect of suprarenal vs. infrarenal
aortic endograft fixation on renal function and renal artery patency: a
comparative study with intermediate follow-up. J
Vasc Surg.
2003;37:1162–1168.
45.
AlricPHinchliffeRJPicotMC. Long-term renal function following
endovascular aneurysm repair with infrarenal and suprarenal aortic
stent-grafts. J Endovasc Ther.
2003;10:397–405.
46.
DaveyPPeastonRRoseJD. Impact on renal function after
endovascular aneurysm repair with uncovered supra-renal fixation assessed by
serum cystatin C. Eur J Vasc Endovasc Surg.
2008;35:439–445.
47.
GreenbergRKChuterTALawrence-BrownM. Analysis of renal function after
aneurysm repair with a device using suprarenal fixation (Zenith AAA
Endovascular Graft) in contrast to open surgical repair.
J Vasc Surg.
2004;39:1219–1228.
48.
SunZStevensonG.
Transrenal fixation of aortic stent-grafts; short to midterm
effects on renal function-a systematic review.
Radiology.
2005;240:65–72.
49.
WalshSRBoyleJRLynchAG. Suprarenal endograft fixation and
medium-term renal function: systematic review and
meta-analysis. J Vasc Surg.
2008;47:1364–1370,e1.
50.
AquinoRVRheeRYMulukSC. Exclusion of accessory renal arteries
during endovascular repair of abdominal aortic aneurysms.
J Vasc Surg.
2001;34:878–884.
51.
KimBDonayreCEHansenCJ. Endovascular abdominal aortic
aneurysm repair using the AneuRx stent graft: impact of excluding accessory
renal arteries. Ann Vasc Surg.
2004;18:32–37.
52.
KarmacharyaJParmerSSAntezanaJN. Outcomes of accessory renal artery
occlusion during endovascular aneurysm repair. J
Vasc Surg.
2006;43:8–13.
53.
GreenbergJIDorseyCDalmanRL. Long-term results after accessory
renal artery coverage during endovascular aortic aneurysm
repair. J Vasc Surg.
2012;56:291–297.
54.
SpearRMaurelBSobocinskiJ. Technical note and results in the
management of anatomical variants of renal vascularisation during
endovascular aneurysm repair. Eur J Vasc Endovasc
Surg.
2012;43:398–403.
55.
SolezKKramerECFoxJA. Medullary plasma flow and
intravascular leukocyte accumulation in acute renal failure.
Kidney Int.
1974;6:24–37.
56.
HellbergPOKallskogOTOjtegG. Peritubular capillary permeability
and intravascular RBC aggregation after ischemia: effects of
neutrophils. Am J Physiol.
1990;258(4 Pt
2):F1018–1025.
57.
ForbesJMHewitsonTDBeckerGJ. Ischemic acute renal failure:
long-term histology of cell and matrix changes in the rat.
Kidney Int.
2000;57:2375–2385.
58.
ForbesJMLeakerBHewitsonTD. Macrophage and myofibroblast
involvement in ischemic acute renal failure is attenuated by endothelin
receptor antagonists. Kidney Int.
1999;55:198–208.
59.
YsebaertDKDe GreefKEVercauterenSR. Identification and kinetics of
leukocytes after severe ischemia/reperfusion renal injury.
Nephrol Dial Transplant.
2000;15:1562–1574.
60.
KielarMLRohan JeyarajahD. The regulation of ischemic acute
renal failure by extrarenal organs. Curr Opin
Nephrol Hypertens.
2002;11:451–457.
61.
SimmonsEMHimmelfarbJSezerMT. Plasma cytokine levels predict
mortality in patients with acute renal failure.
Kidney Int.
2004;65:1357–1365.
62.
De La
MotteLVogtKPanduro JensenL. Incidence of systemic inflammatory
response syndrome after endovascular aortic repair.
J Cardiovasc Surg (Torino).
2011;52:73–79.
63.
NashKHafeezAHouS.
Hospital-acquired renal insufficiency.
Am J Kidney Dis.
2002;39:930–936.
64.
BarrettBJParfreyPS.
Clinical practice. Preventing nephropathy induced by contrast
medium. N Engl J Med.
2006;354:379–386.
StaculFvan der MolenAJReimerP. Contrast induced nephropathy: updated
ESUR Contrast Media Safety Committee guidelines. Eur
Radiol.
2011;21:2527–2541.
67.
MehranRNikolskyE.
Contrast-induced nephropathy: definition, epidemiology, and
patients at risk. Kidney Int Suppl.
2006
Apr(100):S11–15.
68.
GussenhovenMJRavensbergenJvan BockelJH. Renal dysfunction after angiography;
a risk factor analysis in patients with peripheral vascular
disease. J Cardiovasc Surg (Torino).
1991;32:81–86.
69.
MehranRAymongEDNikolskyE. A simple risk score for prediction of
contrast-induced nephropathy after percutaneous coronary intervention:
development and initial validation. J Am Coll
Cardiol.
2004;44:1393–1399.
70.
StaculF.
Reducing the risks for contrast-induced
nephropathy. Cardiovasc Intervent Radiol.
2005;28Suppl 2:S12–18.
71.
StaculFAdamABeckerCR. Strategies to reduce the risk of
contrast-induced nephropathy. Am J Cardiol.
2006;98(6A):59K–77K.
72.
RosovskyMARusinekHBerensteinA. High-dose administration of nonionic
contrast media: a retrospective review.
Radiology.
1996;200:119–122.
73.
VerhoevenELVourliotakisGBosWT. Fenestrated stent grafting for
short-necked and juxtarenal abdominal aortic aneurysm: an 8-year
single-centre experience. Eur J Vasc Endovasc
Surg.
2010;39:529–536.
AivatidiCVourliotakisGGeorgopoulosS. Oxidative stress during abdominal
aortic aneurysm repair–biomarkers and antioxidant's protective
effect: a review. Eur Rev Med Pharmacol
Sci.
2011;15:245–252.
76.
SaracTPBannazadehMRowanAF. Comparative predictors of mortality
for endovascular and open repair of ruptured infrarenal abdominal aortic
aneurysms. Ann Vasc Surg.
2011;25:461–468.
77.
ChewHFYouCKBrownMG. Mortality, morbidity, and costs of
ruptured and elective abdominal aortic aneurysm repairs in Nova Scotia,
Canada. Ann Vasc Surg.
2003;17:171–179.
78.
BlackhouseGHopkinsRBowenJM. A cost-effectiveness model comparing
endovascular repair to open surgical repair of abdominal aortic aneurysms in
Canada. Value Health.
2009;12:245–252.
79.
PeppelenboschNCuypersPWVahlAC. Emergency endovascular treatment for
ruptured abdominal aortic aneurysm and the risk of spinal cord
ischemia. J Vasc Surg.
2005;42:608–614.
80.
CoppiGSilingardiRGennaiS. A single-center experience in open
and endovascular treatment of hemodynamically unstable and stable patients
with ruptured abdominal aortic aneurysms. J Vasc
Surg.
2006;44:1140–1147.
81.
FranksSLloydGFishwickG. Endovascular treatment of ruptured
and symptomatic abdominal aortic aneurysms. Eur J
Vasc Endovasc Surg.
2006;31:345–350.
82.
TakagiHUmemotoT.
A meta-analysis of randomized and risk-adjusted observational
studies of endovascular vs. open repair for ruptured abdominal aortic
aneurysm. Vasc Endovascular Surg.
2011;45:717–719.
83.
NedeauAEPomposelliFBHamdanAD. Endovascular vs open repair for
ruptured abdominal aortic aneurysm. J Vasc
Surg.
2012;56:15–20.
84.
EndreZH.
Renal ischemic preconditioning: finally some good news for
prevention of acute kidney injury. Kidney
Int.
2011;80:796–798.
85.
KharbandaRKNielsenTTRedingtonAN.
Translation of remote ischemic preconditioning into clinical
practice. Lancet.
2009;374:1557–1565.
86.
ShihabFS.
Preconditioning: from experimental findings to novel
therapies in acute kidney injury. Minerva Urol
Nefrol.
2009;61:143–157.
87.
KinseyGRHuangLVergisAL. Regulatory T cells contribute to the
protective effect of ischemic preconditioning in the kidney.
Kidney Int.
2010;77:771–780.
AliZACallaghanCJLimE. Remote ischemic preconditioning
reduces myocardial and renal injury after elective abdominal aortic aneurysm
repair: a randomized controlled trial.
Circulation.
2007;116(11
Suppl):198–105.
90.
RahmanIAMascaroJGSteedsRP. Remote ischemic preconditioning in
human coronary artery bypass surgery: from promise to
disappointment?Circulation. 2010;122(11
Suppl):S53–59.
91.
VenugopalVLaingCMLudmanA. Effect of remote ischemic
preconditioning on acute kidney injury in nondiabetic patients undergoing
coronary artery bypass graft surgery: a secondary analysis of 2 small
randomized trials. Am J Kidney Dis.
2010;56:1043–1049.
92.
ChoiYSShimJKKimJC. Effect of remote ischemic
preconditioning on renal dysfunction after complex valvular heart surgery: a
randomized controlled trial. J Thorac Cardiovasc
Surg.
2011;142:148–154.
93.
ZimmermanRFEzeanunaPUKaneJC. Ischemic preconditioning at a remote
site prevents acute kidney injury in patients following cardiac
surgery. Kidney Int.
2011;80:861–867.
94.
WalshSRBoyleJRTangTY. Remote ischemic preconditioning for
renal and cardiac protection during endovascular aneurysm repair: a
randomized controlled trial. J Endovasc
Ther.
2009;16:680–689.
95.
WalshSRTangTYSadatU. Remote ischemic preconditioning in
major vascular surgery. J Vasc Surg.
2009;49:240–243.
96.
WalshSRTangTYKullarP. Ischemic preconditioning during
cardiac surgery: systematic review and meta-analysis of perioperative
outcomes in randomised clinical trials. Eur J
Cardiothorac Surg.
2008;34:985–994.
97.
StoneGWMcCulloughPATumlinJA. Fenoldopam mesylate for the
prevention of contrast-induced nephropathy: a randomized controlled
trial. JAMA.
2003;290:2284–2291.
98.
TumlinJAWangAMurrayPT. Fenoldopam mesylate blocks reductions
in renal plasma flow after radiocontrast dye infusion: a pilot trial in the
prevention of contrast nephropathy. Am Heart
J.
2002;143:894–903.
99.
LissPNygrenAEriksonU. Injection of low and iso-osmolar
contrast medium decreases oxygen tension in the renal
medulla. Kidney Int.
1998;53:698–702.
100.
GrubeEBaimDBurkhoffD. Local intrarenal fenoldopam infusion
causes greater increases in renal artery flow velocity than systemic
intravenous fenoldopam infusion: a pilot study.
EuroIntervention.
2005;1:305–308.
101.
TeirsteinPSPriceMJMathurVS. Differential effects between
intravenous and targeted renal delivery of fenoldopam on renal function and
blood pressure in patients undergoing cardiac
catheterization. Am J Cardiol.
2006;97:1076–1081.
102.
AllieDELirtzmanMDWyattCH. Targeted renal therapy and
contrast-induced nephropathy during endovascular abdominal aortic aneurysm
repair: results of a feasibility pilot trial. J
Endovasc Ther.
2007;14:520–527.
103.
CaoPZannettiSParlaniG. Epidural anesthesia reduces length of
hospitalization after endoluminal abdominal aortic aneurysm
repair. J Vasc Surg.
1999;30:651–657.
104.
LachatMLPfammatterTWitzkeHJ. Endovascular repair with bifurcated
stent-grafts under local anaesthesia to improve outcome of ruptured
aortoiliac aneurysms. Eur J Vasc Endovasc
Surg.
2002;23:528–536.
105.
VerhoevenELCinaCSTielliuIF. Local anesthesia for endovascular
abdominal aortic aneurysm repair. J Vasc
Surg.
2005;42:402–409.
106.
ParraJRCrabtreeTMcLaffertyR. Anesthesia technique and outcomes of
endovascular aneurysm repair. Ann Vasc
Surg.
2005;19:123–129.
107.
TrivediHNadellaRSzaboA.
Hydration with sodium bicarbonate for the prevention of
contrast-induced nephropathy: a meta-analysis of randomized controlled
trials. Clin Nephrol.
2010;74:288–296.
108.
SolomonRWernerCMannD. Effects of saline, mannitol, and
furosemide to prevent acute decreases in renal function induced by
radiocontrast agents. N Engl J Med.
1994;331:1416–1420.
109.
MertenGJBurgessWPGrayLV. Prevention of contrast-induced
nephropathy with sodium bicarbonate: a randomized controlled
trial. JAMA.
2004;291:2328–2334.
110.
BaderBDBergerEDHeedeMB. What is the best hydration regimen to
prevent contrast media-induced nephrotoxicity?Clin Nephrol.
2004;62:1–7.
111.
TrivediHSMooreHNasrS. A randomized prospective trial to
assess the role of saline hydration on the development of contrast
nephrotoxicity. Nephron Clin Pract.
2003;93:C29–34.
112.
TaylorAJHotchkissDMorseRW. PREPARED: Preparation for Angiography
in Renal Dysfunction: a randomized trial of inpatient vs outpatient
hydration protocols for cardiac catheterization in mild-to-moderate renal
dysfunction. Chest.
1998;114:1570–1574.
113.
KayJChowWHChanTM. Acetylcysteine for prevention of
acute deterioration of renal function following elective coronary
angiography and intervention: a randomized controlled trial.
JAMA.
2003;289:553–558.
114.
MarenziGAssanelliEMaranaI. N-acetylcysteine and contrast-induced
nephropathy in primary angioplasty. N Engl J
Med.
2006;354:2773–2782.
115.
KellyAMDwamenaBCroninP. Metaanalysis: effectiveness of drugs
for preventing contrast-induced nephropathy. Ann
Intern Med.
2008;148:284–294.
116.
CriadoEUpchurchGRYoungK. Endovascular aortic aneurysm repair
with carbon dioxide-guided angiography in patients with renal
insufficiency. J Vasc Surg.
2012;55:1570–1575.
117.
AspelinPAubryPFranssonSG. Nephrotoxic effects in high-risk
patients undergoing angiography. N Engl J
Med.
2003;348:491–499.
118.
BihoracAYavasSSubbiahS. Long-term risk of mortality and acute
kidney injury during hospitalization after major surgery.
Ann Surg.
2009;249:851–858.
119.
StoneGWTumlinJAMadyoonH. Design and rationale of
CONTRAST–a prospective, randomized, placebo-controlled trial of
fenoldopam mesylate for the prevention of radiocontrast
nephropathy. Rev Cardiovasc Med.
2001;2Suppl 1:S31–36.
120.
GreenhalghRMBrownLCKwongGP. Comparison of endovascular aneurysm
repair with open repair in patients with abdominal aortic aneurysm (EVAR
trial 1), 30-day operative mortality results: randomised controlled
trial. Lancet.
2004;364:843–848.
121.
EVAR trial participants.
Endovascular aneurysm repair and outcome in patients unfit
for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised
controlled trial. Lancet.
2005;365(9478):2187–2192.
122.
CuypersPWGardienMButhJ. Randomised study comparing cardiac
response in endovascular and open abdominal aortic aneurysm
repair. Br J Surg.
2001;88:1059–1065.
123.
TreharneGDThompsonMMWhiteleyMS. Physiological comparison of open and
endovascular aneurysm repair. Br J Surg.
1999;86:760–764.
124.
MehtaMVeithFJLipsitzEC. Is elevated creatinine level a
contraindication to endovascular aneurysm repair?J Vasc Surg.
2004;39:118–123.
125.
SemmensJBLawrence-BrownMMHartleyDE. Outcomes of fenestrated endografts in
the treatment of abdominal aortic aneurysm in Western Australia
(1997–2004). J Endovasc Ther.
2006;13:320–329.
126.
AndersonJLBerceMHartleyD.
Endoluminal aortic grafting with renal and superior
mesenteric artery incorporation by graft fenestration.
J Endovasc Ther.
2001;8:3–15.
ZieglerPAvgerinosEDUmscheidT. Fenestrated endografting for aortic
aneurysm repair: a 7-year experience. J Endovasc
Ther.
2007;14:609–618.
130.
GreenbergRKSternberghWCMakarounM. Intermediate results of a United
States multicenter trial of fenestrated endograft repair for juxtarenal
abdominal aortic aneurysms. J Vasc Surg.
2009;50:730–737.e1.
131.
TambyrajaALFishwickNGBownMJ. Fenestrated aortic endografts for
juxtarenal aortic aneurysm: medium term outcomes.
Eur J Vasc Endovasc Surg.
2011;42:54–58.
